U.S. Pharmacy Market Size, Share & COVID-19 Impact Analysis, By Type (Branded and Generics); By Therapy Class (Oncology, Anti-diabetics, Autoimmune Diseases, Respiratory, Pain, Nervous System Disorders, Dermatology, Antihypertensive, Mental Health, HIV Antivirals, Multiple Sclerosis, Anticoagulants, Other Cardiovascular, ADHD, GI Products, Viral Hepatitis, Sex Hormones, Antibacterial, Hormonal Contraception, Ophthalmology, and Others), By Setting (Retail Pharmacies, Mail Order/Online Pharmacies, Others), Regional Forecast, 2021-2028

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI106306

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2017-2028
Base Year	2020
Estimated Year	2021
Forecast Period	2021-2028
Historical Period	2017-2019
Unit	Value (USD Billion)
Segmentation	Type, Therapy Class, and Setting
By Type	Branded Generics
By Therapy Class	Oncology Anti-diabetics Autoimmune diseases Respiratory Pain Nervous System Disorders Dermatology Antihypertensive Mental Health HIV Antivirals Multiple Sclerosis Anticoagulants Other Cardiovascular ADHD GI Products Viral Hepatitis Sex Hormones Antibacterial Hormonal Contraception Ophthalmology Others
By Setting	Retail Pharmacies Mail Order/Online Pharmacies Others (Non-retail Settings)